Rediscover Microbiology

Rediscover
Microorganisms

Empowering Precision Health via the Gut Microbiota

Expanding our horizons, discovering new insights,
and forging a healthier future through the power of microorganisms.
Expanding our horizons, discovering new insights, and forging a healthier future through the power of microorganisms.

Rediscover Microbiology

Founded in August 2011 as a spin-off from National Taiwan University, Leeuwenhoek Biotech Inc. specializes in microbial multi-omics technology services and is committed to developing
innovative products and solutions that promote metabolic health through gut microbiota modulation..
Rooted in science, we explore groundbreaking applications of the gut microbiome in human health—empowering microbes to become a key force in shaping the future of wellness.
Leeuwenhoek was founded in August 2011 as a start-up company derived from the technology transfer of National Taiwan University. We focus on providing microbial polysomics technology services and are committed to developing innovative services and products that promote metabolic health through intestinal flora regulation.
Rooted in science, we explore groundbreaking applications of the gut microbiome in human health—empowering microbes to become a key force in shaping the future of wellness.

Three core technologies

We house the world’s largest Akkermansia strain biobank for next-generation probiotics,
the third-largest gut microbial metabolomics database globally, and a proprietary synbiotic technology platform
—positioning us at the forefront of gut health research and innovation.
Leeuwenhoek has the world's largest resource library of next-generation probiotic Akkermansia strains, the world's third largest intestinal bacterial metabolite database, and an independently developed next-generation synbiotic technology platform, which establishes our leading position in intestinal health research and application.

Rediscover Microbiology

Leeuwenhoek connects the final piece of the puzzle
Unlocking breakthroughs in the future of biotechnology
Cumulative Samples Analyzed in Taiwan from Dec 2024 to Present
Microscope 2

Academic and Research Institutions

0 +

Medical Institutions

0 +

Industry Clients

0 +
Based on scientific evidence and supported by experimental results
Your best partner in research

Latest News & Events

Insights & Highlights